Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-12-14 5:51 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Genextra S.p.A. | 2,525,950 5.89% | 2,525,950 (New Position) | View |
| 2022-09-02 4:58 pm Sale | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 4,000,000 13.4% | -31,994 (-0.79%) | View |
| 2020-08-31 4:30 pm Sale | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 4,031,994 12.2% | -1,500,000 (-27.11%) | View |
| 2020-05-15 5:24 pm Sale | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 5,531,994 16.8% | -591,834 (-9.66%) | View |
| 2019-07-31 4:30 pm Purchase | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 6,123,828 20.6% | 28,250 (+0.46%) | View |